PubmedID,Title,Publication Date,NonAcademic Authors,Company Affiliations,Corresponding Author Email
40631259,KAT6A/B inhibition synergizes with retinoic acid and enhances the efficacy of GD2-targeted immunotherapy in neuroblastoma.,2025,,,
40631163,TLR2 signaling uniquely destabilizes tumor Tregs to promote cancer immunotherapy.,2025,,,
40631140,Longitudinal Proteomic Profiling of T Cell Differentiation In Vivo Reveals Biochemical Remodeling Underlying Exhaustion.,2025,,,
40631030,"Physician specialty shapes hypothetical self-treatment choices for locally advanced non-small cell lung cancer: Is the ""best"" option subjective?",2025,,"Thoracic and Cardiovascular Surgery, UT MD Anderson Cancer Center, Houston, Tex.; Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.; Medical Oncology, St. James's Hospital, Dublin, Ireland.; Thoracic Oncology, The Royal Marsden, London, United Kingdom.; Thoracic Surgery, Montefiore Medical Center, Bronx, NY.; Thoracic Surgery, St. James's University Hospital, Leeds, United Kingdom.",
40630962,Benign tumors broaden the field of application for immunotherapy.,2025,,"Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, United States.; Department of Pathology, The University of Texas Medical Branch, Galveston, TX, United States.; Department of Medical Oncology, Ohio State University, Columbus, OH, United States.; Departments of Dermatology, Microbiology and Immunology, Robert H. Lurie Comprehensive Cancer Center, North Western University, Chicago, IL, United States.; Department of Pathology, Loyola University Medical Center, Maywood, IL, United States.; Departments of Dermatology, Microbiology and Immunology, Robert H. Lurie Comprehensive Cancer Center, North Western University, Chicago, IL, United States.",
